A bill to improve enforcement efforts related to prescription drug diversion and abuse, and for other purposes.
Sponsor and status
114th Congress (2015–2017)
Enacted — Signed by the President on Apr 19, 2016
This bill was enacted after being signed by the President on April 19, 2016.
4 Cosponsors (3 Republicans, 1 Democrat)
Position statements
What legislators are saying
“Welch-Cosponsored Prescription Drug Diversion Legislation Heads to Obama for Signature”
—
Sen. Peter Welch [D-VT]
on Apr 13, 2016
“50th ANNIVERSARY OF JAMES MEREDITHS HISTORIC MARCH AGAINST FEAR HONORED”
—
Sen. Thad Cochran [R-MS, 1979-2018]
on Jun 13, 2016
“Grassley Statement at an Executive Business Meeting”
—
Sen. Charles “Chuck” Grassley [R-IA]
on Jan 28, 2016
Incorporated legislation
This bill incorporates provisions from:
H.R. 471: Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Passed House (Senate next) on Apr 21, 2015. 85% incorporated. (compare text)
History
|
Feb 12, 2015
|
|
Introduced
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber. |
|
Apr 21, 2015
|
|
Source Bill —
Passed House (Senate next)
This activity took place on a related bill, H.R. 471 (114th), possibly in lieu of similar activity on S. 483 (114th). |
|
Dec 10, 2015
|
|
Considered by Senate Committee on the Judiciary
A committee held a hearing or business meeting about the bill.
|
|
Jan 21, 2016
|
|
Considered by Senate Committee on the Judiciary
A committee held a hearing or business meeting about the bill.
|
|
Jan 28, 2016
|
|
Considered by Senate Committee on the Judiciary
A committee held a hearing or business meeting about the bill.
|
|
Feb 11, 2016
|
|
Ordered Reported
A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee. |
|
Mar 17, 2016
|
|
Passed Senate (House next)
The bill was passed in a vote in the Senate. It goes to the House next. The vote was by Unanimous Consent so no record of individual votes was made. |
|
Apr 12, 2016
|
|
Passed House
The bill was passed by both chambers in identical form. It goes to the President next who may sign or veto the bill. The vote was without objection so no record of individual votes was made. |
|
Apr 19, 2016
|
|
Enacted — Signed by the President
The President signed the bill and it became law.
|
S. 483 (114th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
Bills numbers restart every two years. That means there are other bills with the number S. 483. This is the one from the 114th Congress.
This bill was introduced in the 114th Congress, which met from Jan 6, 2015 to Jan 3, 2017. Legislation not passed by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
“S. 483 — 114th Congress: Ensuring Patient Access and Effective Drug Enforcement Act of 2016.” www.GovTrack.us. 2015. September 29, 2023 <https://www.govtrack.us/congress/bills/114/s483>
- show another citation format:
- APA
- Blue Book
- Wikipedia Template
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.
